Quantcast

Latest biotechnology Stories

2014-09-30 12:29:30

WORCESTER, Mass. and TORONTO, Sept. 30, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has engaged Dr. Lakshmi P. Kotra, B. Pharm.(Hons), Ph.D., as a consultant to the Company to provide expertise and assistance in the management of the Company's previously announced buccal insulin enhancement project. In this role, Dr. Kotra will work closely with the Company's Senior Scientific Advisor, Dr. James H. Anderson, Jr., MD,...

2014-09-30 08:33:20

Intelligent Bioprocess Data Management System MILFORD, Mass., Sept. 30, 2014 /PRNewswire/ -- Spectra Automation, a trusted supplier of process control solutions for the biotech and power generation industries, announced today the availability of its new RECONN Bioprocess Manager, an easy-to-use and cost-effective data collection, analysis and reporting solution geared towards bioprocess development laboratories. Most upstream process development facilities have disparate bioreactor...

2014-09-30 08:32:17

SAN FRANCISCO, Sept. 30, 2014 /PRNewswire/ -- Twist Bioscience today announced that it secured a loan facility of up to $10 million with Silicon Valley Bank. http://photos.prnewswire.com/prnvar/20140526/91128 "We continue to advance the development of our game-changing platform and user experience that will accelerate scientific discovery as we look to rapidly deliver high-quality, low cost, high-throughput synthetic DNA to our customers," said Emily Leproust, Ph.D., chief...

2014-09-30 08:31:56

SHANGHAI, Sept. 30, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced the appointment of William Robert Keller as an independent director on the Board of Directors. He will serve on the Strategy Committee. Mr. Keller was the general manager of Roche China Ltd. and Shanghai Roche Pharmaceutical Ltd. from 1994 to 2003, and...

2014-09-30 08:31:55

ST. LOUIS, Sept. 30, 2014 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held regenerative medicine company, announced today announced that Mitchell Seyedin, Ph.D., the Company's Executive Chairman, will present at the 4th Annual Partnering Forum, part of the Stem Cell Meeting on the Mesa, as follows: Event: 2014 Stem Cell Meeting on the Mesa - Partnering Forum Date: October 7, 2014 Time: 11:15 am PDT Location:...

2014-09-30 08:29:03

NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information. The healthcare market research publisher said that over 100 deals had occurred in proteomics in the past two years. The activity ranges from investments and IPOs, to agreements between private proteomic companies and academic institutions, to deals between pharma and biotech companies with novel proteomics innovator companies. Kalorama...

2014-09-29 16:25:44

ORLANDO, Fla. and DUBLIN, Sept. 29, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing both US and Internationally as well as the marketing of innovative therapies for cancer, HIV/AIDS, opportunistic infections and autoimmune diseases in emerging nations, issued a letter to its shareholders from CEO Noreen Griffin The letter follows: Dear Shareholders, TNI BioTech, Inc. (the "Company" or "TNIB")...

2014-09-29 16:25:23

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Oligonucleotide Synthesis Market by Product & Services, End-User , Application - Global Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. The global oligonucleotide synthesis market is...

2014-09-29 08:29:58

MARLBOROUGH, Mass., Sept. 29, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 13(th) Annual BIO Investor Forum on Tuesday, October 7, 2014 at 10:00 a.m. PST. Dr. Cauwenbergh will...

2014-09-29 08:26:42

South Korea emerges among the frontrunners in the race to lead the global biosimilars market PHILADEPHIA, Sept. 29, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the release of Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014 .The new report, compiled by Thomson Reuters BioWorld, the premier...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related